Want to join the conversation?
Citi Group analyst Jim Suva questions $SNX whether Concentrix's challenged contract is expected to show modest profit in 3Q16. EVP Concentrix Chris Caldwell says that $SNX expects a modest profit within 3Q16 and there is some backloading on that contract in 3Q16 and 4Q16. The company expects it to be marginally profitable when looking at FY16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?